Fast delivery 99% Enrofloxacin hydrochloride/hcl powder CAS:112732-17-9

Product information

Enrofloxacin hydrochloride is a synthetic third generation quinolone antibacterial drug, which is a special new drug for the prevention and treatment of livestock, poultry and aquatic diseases. It not only retains the characteristics of quinolone drugs with broad spectrum, high efficiency, low toxicity, good absorption Chemicalbook and convenient administration, but also has a significant effect on various infections caused by a variety of bacteria. In particular, the lethality of mycoplasma was significantly higher than that of other quinolone drugs, tylosin, tiemomycin and other drugs.

Product Application:

1.Antibacterial API, mainly used for livestock and poultry bacteria and mycoplasma infection.

2.For respiratory tract, digestive tract, urinary tract, reproductive system and systemic infection of livestock and poultry. Sea, fresh water fish rotten gill, enteritis, rotten tail disease and other bacterial infections.

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.